UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment

Cancer letters, 2018-06, Vol.423, p.9-15

2018

Volltextzugriff (PDF)

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

Pharmacological research, 2023-08, Vol.194, p.106844-106844, Article 106844

2023

Volltextzugriff (PDF)

Subjecting appropriate lung adenocarcinoma samples to next‐generation sequencing‐based molecular testing: challenges and possible solutions

Molecular oncology, 2018-05, Vol.12 (5), p.677-689

2018

Volltextzugriff (PDF)

Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma

Pharmacological research, 2023-06, Vol.192, p.106800-106800, Article 106800

2023

Volltextzugriff (PDF)

Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency

Genomics, proteomics & bioinformatics, 2023-10, Vol.21 (5), p.962-975

2023

Volltextzugriff (PDF)

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients

Lung cancer (Amsterdam, Netherlands), 2015-09, Vol.89 (3), p.337-342

2015

Volltextzugriff (PDF)

Programmable endonuclease combined with isothermal polymerase amplification to selectively enrich for rare mutant allele fractions

Chinese chemical letters, 2022-08, Vol.33 (8), p.4126-4132

2022

Volltextzugriff (PDF)

Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes

Breast (Edinburgh), 2020-10, Vol.53 (C), p.143-151

2020

Volltextzugriff (PDF)

Aberrant Promoter Methylation of DLEC1 , a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage

The Journal of urology, 2010-08, Vol.184 (2), p.731-737

2010

Volltextzugriff (PDF)

Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing

Cancer letters, 2017-12, Vol.410, p.92-99

2017

Volltextzugriff (PDF)

Epigenetic Silencing of a Proapoptotic Cell Adhesion Molecule, the Immunoglobulin Superfamily Member IGSF4, by Promoter CpG Methylation Protects Hodgkin Lymphoma Cells from Apoptosis

The American journal of pathology, 2010-09, Vol.177 (3), p.1480-1490

2010

Volltextzugriff (PDF)

Acquired EGFR L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib

Lung cancer (Amsterdam, Netherlands), 2018-04, Vol.118, p.1-5

2018

Volltextzugriff (PDF)

PD18-02 NEUTROPHIL EXTRACELLULAR TRAPS IN RELATIONSHIP TO EFFICACY OF SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B

The Journal of thoracic and cardiovascular surgery, 2018-06, Vol.155 (6), p.e185-e191

2018

Volltextzugriff (PDF)

The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma

Pathology, research and practice, 2022-08, Vol.236, p.153934-153934, Article 153934

2022

Volltextzugriff (PDF)

Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants

Lung cancer (Amsterdam, Netherlands), 2018-04, Vol.118, p.128-133

2018

Volltextzugriff (PDF)

Anisotropic porous structure modeling for 3D printed objects

Computers & graphics, 2018-02, Vol.70, p.157-164

2018

Volltextzugriff (PDF)

EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study

Lung cancer (Amsterdam, Netherlands), 2020-07, Vol.145, p.186-194

2020

Volltextzugriff (PDF)

MP28-11 LONG-TERM PROGNOSIS AND RISK STRATIFICATION FOR ADULT MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction

Pathology, research and practice, 2019-03, Vol.215 (3), p.483-489

2019

Volltextzugriff (PDF)

Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators

Cancer cell, 2024-06, Vol.42 (6), p.1106-1125.e8

2024

Volltextzugriff (PDF)

Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery

Human pathology, 2021-02, Vol.108, p.84-92

2021

Volltextzugriff (PDF)

Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84–92]

Human pathology, 2022-07, Vol.125, p.1-1

2022

Volltextzugriff (PDF)

Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas

Lung cancer (Amsterdam, Netherlands), 2018-08, Vol.122, p.113-119

2018

Volltextzugriff (PDF)

Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis

Cancer letters, 2014-11, Vol.354 (2), p.227-234

2014

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(144)

Sprache

Englisch
(144)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

Subjecting appropriate lung adenocarcinoma samples to next‐generation sequencing‐based molecular testing: challenges and possible solutions

Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma

Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients

Programmable endonuclease combined with isothermal polymerase amplification to selectively enrich for rare mutant allele fractions

Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes

Aberrant Promoter Methylation of DLEC1 , a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage

Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing

Epigenetic Silencing of a Proapoptotic Cell Adhesion Molecule, the Immunoglobulin Superfamily Member IGSF4, by Promoter CpG Methylation Protects Hodgkin Lymphoma Cells from Apoptosis

Acquired EGFR L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib

PD18-02 NEUTROPHIL EXTRACELLULAR TRAPS IN RELATIONSHIP TO EFFICACY OF SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA

Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B

The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma

Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants

Anisotropic porous structure modeling for 3D printed objects

EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study

MP28-11 LONG-TERM PROGNOSIS AND RISK STRATIFICATION FOR ADULT MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA

NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction

Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators

Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery

Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84–92]

Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas

Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis

Aktive Filter

Suchergebnisse filtern